Ren-Wang PENG

Group Leader | Translational Cancer Research | University of Bern Chinese Academy of Sciences • Max Planck Institute • ETH Zürich

Bern, Berne, Switzerland

About

Group Leader at the University of Bern (Switzerland) working in cancer biology and translational cancer research. Trained and formerly appointed at the Chinese Academy of Sciences (China), Max Planck Institute for Biophysical Chemistry (Germany), Dartmouth Medical School (USA), and ETH Zürich (Switzerland). My research team focuses on identifying molecular vulnerabilities in cancer and translating mechanistic insights into clinically relevant strategies, integrating functional genomics and multi-omics approaches in close collaboration with clinicians. Key Areas Cancer Biology · Translational Cancer Research · Therapy Resistance · Functional Genomics · Multi-omics

Experience

  • Professor at University of Bern
    Dec 2012 - Jan 2022 · 9 yrs 2 mos

  • Group Leader at ETH Zürich
    2006 - 2010 · 4 yrs

  • Junior group leader at Max Planck Institute for Biophysical Chemistry
    2000 - 2006 · 6 yrs

  • Visiting Scientist at DARTMOUTH MEDICAL SCHOOL
    1999 - 1999 · Less than a year

  • Postdoc at Max Planck Institute for Biophysical Chemistry
    1996 - 1998 · 2 yrs